TW201429974A - 三環化合物 - Google Patents
三環化合物 Download PDFInfo
- Publication number
- TW201429974A TW201429974A TW102147023A TW102147023A TW201429974A TW 201429974 A TW201429974 A TW 201429974A TW 102147023 A TW102147023 A TW 102147023A TW 102147023 A TW102147023 A TW 102147023A TW 201429974 A TW201429974 A TW 201429974A
- Authority
- TW
- Taiwan
- Prior art keywords
- dimethyl
- dione
- pyrrolo
- pyrimido
- dihydro
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 307
- 150000003839 salts Chemical class 0.000 claims abstract description 64
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 21
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims description 288
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 90
- -1 Dimethyl-5-(4-methylthiazol-2-yl)-7,8-dihydro-1H-pyrimido[4',5':3,4]pyrrolo[2,1-c][ 1,4]thiazine-2,4(3H,10H)-dione Chemical compound 0.000 claims description 82
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 73
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 44
- 206010012735 Diarrhoea Diseases 0.000 claims description 42
- 125000005843 halogen group Chemical group 0.000 claims description 41
- 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 claims description 39
- 238000011282 treatment Methods 0.000 claims description 36
- 229910052739 hydrogen Inorganic materials 0.000 claims description 34
- 239000001257 hydrogen Substances 0.000 claims description 34
- 201000010099 disease Diseases 0.000 claims description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 30
- 125000004941 pyridazin-5-yl group Chemical group N1=NC=CC(=C1)* 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 26
- 125000001424 substituent group Chemical group 0.000 claims description 25
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 22
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 20
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 17
- 125000004432 carbon atom Chemical group C* 0.000 claims description 17
- 208000030761 polycystic kidney disease Diseases 0.000 claims description 17
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 16
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 claims description 16
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 14
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims description 14
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 14
- 229910052760 oxygen Inorganic materials 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 10
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 claims description 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 125000004429 atom Chemical group 0.000 claims description 8
- 125000005842 heteroatom Chemical group 0.000 claims description 8
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 claims description 7
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims description 7
- 125000003282 alkyl amino group Chemical group 0.000 claims description 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 7
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 7
- 125000000335 thiazolyl group Chemical group 0.000 claims description 7
- 125000001544 thienyl group Chemical group 0.000 claims description 7
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- HODVQYQNLRXFNK-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound O1C(C)=NN=C1C1=C2C(=O)N(C)C(=O)N(C)C2=C2C(C=3OC(Cl)=CC=3)SCCN21 HODVQYQNLRXFNK-UHFFFAOYSA-N 0.000 claims description 5
- DBMBAPUQYZUKHG-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SC(CO)CN32)=N1 DBMBAPUQYZUKHG-UHFFFAOYSA-N 0.000 claims description 5
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 5
- 125000002541 furyl group Chemical group 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 125000006536 (C1-C2)alkoxy group Chemical group 0.000 claims description 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 4
- ULTQGYQOQUFXDC-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(1-methylpyrazol-3-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CN1C=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SC(CO)CN32)=N1 ULTQGYQOQUFXDC-UHFFFAOYSA-N 0.000 claims description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 3
- VEVARMXPPWZFND-UHFFFAOYSA-N 1,3-dimethyl-10-(4-methyl-1,3-thiazol-2-yl)-5-phenyl-7,8,9,10-tetrahydropyrimido[1,2]pyrrolo[4,5-b]pyridazine-2,4-dione Chemical compound CC1=CSC(C2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)NCC2)=N1 VEVARMXPPWZFND-UHFFFAOYSA-N 0.000 claims description 3
- HMVYYTRDXNKRBQ-UHFFFAOYSA-N 1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC=N1 HMVYYTRDXNKRBQ-UHFFFAOYSA-N 0.000 claims description 3
- FMMKKYIEZSJODV-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SCCN32)=N1 FMMKKYIEZSJODV-UHFFFAOYSA-N 0.000 claims description 3
- VYIFXMDXJZVGMQ-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3OC(Cl)=CC=3)SCCN2C=1C1=CC=CC=C1 VYIFXMDXJZVGMQ-UHFFFAOYSA-N 0.000 claims description 3
- WZBSYUDTBIEPPK-UHFFFAOYSA-N 5-(3-chlorophenyl)-1,3-dimethyl-10-(4-methyl-1,3-thiazol-2-yl)-7,8,9,10-tetrahydropyrimido[1,2]pyrrolo[4,5-b]pyridazine-2,4-dione Chemical compound CC1=CSC(C2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=C(Cl)C=CC=3)NCC2)=N1 WZBSYUDTBIEPPK-UHFFFAOYSA-N 0.000 claims description 3
- ZYILWZGTSMNONG-UHFFFAOYSA-N 7-[(dimethylamino)methyl]-1,3-dimethyl-10-(5-methylfuran-2-yl)-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=1C=CC=CC=1C1=C(C(N(C)C(=O)N2C)=O)C2=C2N1C(CN(C)C)CSC2C1=CC=C(C)O1 ZYILWZGTSMNONG-UHFFFAOYSA-N 0.000 claims description 3
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- SCWJMTRWNKOOKE-UHFFFAOYSA-N 1,3,8-trimethyl-10-(4-methyl-1,3-thiazol-2-yl)-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S1C(C)CN(C(=C2C(=O)N(C)C(=O)N(C)C2=2)C=3C=CC=CC=3)C=2C1C1=NC(C)=CS1 SCWJMTRWNKOOKE-UHFFFAOYSA-N 0.000 claims description 2
- OMKFKEYPKXLIDM-UHFFFAOYSA-N 1,3-dimethyl-10-(5-methylthiophen-2-yl)-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S1C(C)=CC=C1C1C2=C(N(C)C(=O)N(C)C3=O)C3=C(C=3C=CC=CC=3)N2CCS1 OMKFKEYPKXLIDM-UHFFFAOYSA-N 0.000 claims description 2
- KBXXSTGPDJDKPZ-UHFFFAOYSA-N 1,3-dimethyl-11-(4-methyl-1,3-thiazol-2-yl)-5-phenyl-8,9,10,11-tetrahydro-7h-pyrimido[1,2]pyrrolo[4,5-a]azepine-2,4-dione Chemical compound CC1=CSC(C2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)CCCC2)=N1 KBXXSTGPDJDKPZ-UHFFFAOYSA-N 0.000 claims description 2
- NODRNSUBQQBWEJ-UHFFFAOYSA-N 10-(4-chloro-1,3-thiazol-2-yl)-5-[4-(hydroxymethyl)-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3SC=C(Cl)N=3)SCCN2C=1C1=NC(CO)=CS1 NODRNSUBQQBWEJ-UHFFFAOYSA-N 0.000 claims description 2
- CTTIOMZLKYKEKX-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-diethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(CC)C(=O)N(CC)C2=C2C(C=3OC(Cl)=CC=3)SCCN2C=1C1=CC=CC=C1 CTTIOMZLKYKEKX-UHFFFAOYSA-N 0.000 claims description 2
- NRFUJNSPJPMOJX-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(1-methylpyrazol-4-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C1=NN(C)C=C1C1=C2C(=O)N(C)C(=O)N(C)C2=C2C(C=3OC(Cl)=CC=3)SCCN21 NRFUJNSPJPMOJX-UHFFFAOYSA-N 0.000 claims description 2
- IVAOJSCNZXBWCF-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(3-methylphenyl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CC=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SCCN32)=C1 IVAOJSCNZXBWCF-UHFFFAOYSA-N 0.000 claims description 2
- HGIIJMBAUDLRQN-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(2-methyl-1,3-thiazol-4-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S1C(C)=NC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SC(CO)CN32)=C1 HGIIJMBAUDLRQN-UHFFFAOYSA-N 0.000 claims description 2
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 claims description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 229960002155 chlorothiazide Drugs 0.000 claims description 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 2
- ZVWHNWKIKAKMBA-UHFFFAOYSA-N 10-(3-chlorophenyl)-1,3-dimethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3C=C(Cl)C=CC=3)SCCN2C=1C1=CC=CC=C1 ZVWHNWKIKAKMBA-UHFFFAOYSA-N 0.000 claims 2
- BBKGYGFXPBKJAB-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-5-(3-ethoxyphenyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CCOC1=CC=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SCCN32)=C1 BBKGYGFXPBKJAB-UHFFFAOYSA-N 0.000 claims 2
- YYMSODGVZHNXDE-UHFFFAOYSA-N 10-(4-chloro-1,3-thiazol-2-yl)-5-(3-fluorophenyl)-8-(hydroxymethyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3SC=C(Cl)N=3)SC(CO)CN2C=1C1=CC=CC(F)=C1 YYMSODGVZHNXDE-UHFFFAOYSA-N 0.000 claims 1
- JKYQAJRHBLIHNN-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(1-methylimidazol-4-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CN1C=NC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SCCN32)=C1 JKYQAJRHBLIHNN-UHFFFAOYSA-N 0.000 claims 1
- BSHCBORTLOSSJM-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-5-(3-methoxyphenyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound COC1=CC=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SCCN32)=C1 BSHCBORTLOSSJM-UHFFFAOYSA-N 0.000 claims 1
- RVXYBSFWYANPGV-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-5-(cyclohexen-1-yl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3OC(Cl)=CC=3)SCCN2C=1C1=CCCCC1 RVXYBSFWYANPGV-UHFFFAOYSA-N 0.000 claims 1
- KGBBKIRQNQXTLL-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3OC(Cl)=CC=3)SC(CO)CN2C=1C1=CC=CC=C1 KGBBKIRQNQXTLL-UHFFFAOYSA-N 0.000 claims 1
- GGKFHMXFNJQQFD-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-8-[(dimethylamino)methyl]-1,3-dimethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S1C(CN(C)C)CN(C(=C2C(=O)N(C)C(=O)N(C)C2=2)C=3C=CC=CC=3)C=2C1C1=CC=C(Cl)O1 GGKFHMXFNJQQFD-UHFFFAOYSA-N 0.000 claims 1
- ZGVYRUCPMUAXAH-UHFFFAOYSA-N 11-(4-chloro-1,3-thiazol-2-yl)-5-(3-fluorophenyl)-1,3-dimethyl-8,9,10,11-tetrahydro-7h-pyrimido[1,2]pyrrolo[4,5-a]azepine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3SC=C(Cl)N=3)CCCCN2C=1C1=CC=CC(F)=C1 ZGVYRUCPMUAXAH-UHFFFAOYSA-N 0.000 claims 1
- 102000008371 intracellularly ATP-gated chloride channel activity proteins Human genes 0.000 claims 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 239000013543 active substance Substances 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 569
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 327
- 235000019439 ethyl acetate Nutrition 0.000 description 279
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 251
- 239000000203 mixture Substances 0.000 description 233
- 239000000543 intermediate Substances 0.000 description 223
- 238000005481 NMR spectroscopy Methods 0.000 description 203
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 201
- 238000000034 method Methods 0.000 description 169
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 128
- 239000012071 phase Substances 0.000 description 95
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 94
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 90
- 238000004808 supercritical fluid chromatography Methods 0.000 description 85
- 239000000243 solution Substances 0.000 description 80
- 229910052796 boron Inorganic materials 0.000 description 77
- 229910002091 carbon monoxide Inorganic materials 0.000 description 73
- 238000001514 detection method Methods 0.000 description 73
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 71
- 239000011541 reaction mixture Substances 0.000 description 65
- 238000006243 chemical reaction Methods 0.000 description 64
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 64
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 62
- 238000000926 separation method Methods 0.000 description 62
- 238000004587 chromatography analysis Methods 0.000 description 58
- 239000000284 extract Substances 0.000 description 51
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 49
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 49
- 229920006395 saturated elastomer Polymers 0.000 description 48
- 239000012074 organic phase Substances 0.000 description 45
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 42
- 239000002904 solvent Substances 0.000 description 40
- 239000002585 base Substances 0.000 description 39
- 230000002209 hydrophobic effect Effects 0.000 description 38
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 36
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 35
- 102000012605 Cystic Fibrosis Transmembrane Conductance Regulator Human genes 0.000 description 35
- 239000000725 suspension Substances 0.000 description 34
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 33
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 32
- 239000007787 solid Substances 0.000 description 32
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 28
- 239000002253 acid Substances 0.000 description 26
- 230000014759 maintenance of location Effects 0.000 description 26
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 25
- 239000003795 chemical substances by application Substances 0.000 description 25
- 235000019441 ethanol Nutrition 0.000 description 25
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 25
- 230000002829 reductive effect Effects 0.000 description 24
- 239000000460 chlorine Substances 0.000 description 23
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 23
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 22
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 22
- 239000012267 brine Substances 0.000 description 22
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 19
- 229940124597 therapeutic agent Drugs 0.000 description 19
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 18
- NXFFJDQHYLNEJK-UHFFFAOYSA-N 2-[4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1h-cyclopenta[b]indol-3-yl]acetic acid Chemical compound C1=2C(S(=O)(=O)C)=CC(F)=CC=2C=2CCC(CC(O)=O)C=2N1CC1=CC=C(Cl)C=C1 NXFFJDQHYLNEJK-UHFFFAOYSA-N 0.000 description 17
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 17
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 16
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 16
- 239000007858 starting material Substances 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- PAQZWJGSJMLPMG-UHFFFAOYSA-N 2,4,6-tripropyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 description 14
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 14
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 14
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 14
- 235000019341 magnesium sulphate Nutrition 0.000 description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 14
- 229910000420 cerium oxide Inorganic materials 0.000 description 13
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 13
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 13
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 13
- 229910052763 palladium Inorganic materials 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 239000012279 sodium borohydride Substances 0.000 description 12
- 229910000033 sodium borohydride Inorganic materials 0.000 description 12
- 239000012312 sodium hydride Substances 0.000 description 12
- 229910000104 sodium hydride Inorganic materials 0.000 description 12
- 239000003643 water by type Substances 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 11
- VYLVYHXQOHJDJL-UHFFFAOYSA-K cerium trichloride Chemical compound Cl[Ce](Cl)Cl VYLVYHXQOHJDJL-UHFFFAOYSA-K 0.000 description 11
- 230000001404 mediated effect Effects 0.000 description 11
- 229910052938 sodium sulfate Inorganic materials 0.000 description 11
- 235000011152 sodium sulphate Nutrition 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- QIMGXLKMKVECKA-UHFFFAOYSA-N 1,10-dihydropyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C1SC=CN2C=C(C(=O)NC(=O)N3)C3=C21 QIMGXLKMKVECKA-UHFFFAOYSA-N 0.000 description 10
- WOUPIOIURYZNRU-UHFFFAOYSA-N 2-bromo-4-chloro-1,3-thiazole Chemical compound ClC1=CSC(Br)=N1 WOUPIOIURYZNRU-UHFFFAOYSA-N 0.000 description 10
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 10
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 10
- 235000019253 formic acid Nutrition 0.000 description 10
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 9
- XRNLDNHTFMNHKA-UHFFFAOYSA-M [Cl-].C(C)(C)[Mg+].Cl Chemical compound [Cl-].C(C)(C)[Mg+].Cl XRNLDNHTFMNHKA-UHFFFAOYSA-M 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- 238000010348 incorporation Methods 0.000 description 9
- 201000009881 secretory diarrhea Diseases 0.000 description 9
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 8
- DGAUAVDWXYXXGQ-UHFFFAOYSA-N 5-chlorofuran-2-carbaldehyde Chemical compound ClC1=CC=C(C=O)O1 DGAUAVDWXYXXGQ-UHFFFAOYSA-N 0.000 description 8
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 8
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 8
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 8
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 8
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- 150000001299 aldehydes Chemical class 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 230000002458 infectious effect Effects 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 7
- JBMKAUGHUNFTOL-UHFFFAOYSA-N Aldoclor Chemical class C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NC=NS2(=O)=O JBMKAUGHUNFTOL-UHFFFAOYSA-N 0.000 description 7
- GOGNOZQZAAGMEE-UHFFFAOYSA-N CN1C(=C(C(=O)N(C1=O)C)SCC2=CC=CC=C2)CBr Chemical compound CN1C(=C(C(=O)N(C1=O)C)SCC2=CC=CC=C2)CBr GOGNOZQZAAGMEE-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
- 201000003883 Cystic fibrosis Diseases 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 7
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 7
- 229910000024 caesium carbonate Inorganic materials 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 150000004820 halides Chemical class 0.000 description 7
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 7
- 239000012044 organic layer Substances 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 235000015424 sodium Nutrition 0.000 description 7
- 239000003451 thiazide diuretic agent Substances 0.000 description 7
- VQKFNUFAXTZWDK-UHFFFAOYSA-N 2-Methylfuran Chemical compound CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- 239000002841 Lewis acid Substances 0.000 description 6
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 6
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 238000005984 hydrogenation reaction Methods 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 150000002576 ketones Chemical class 0.000 description 6
- 150000007517 lewis acids Chemical class 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- IZDROVVXIHRYMH-UHFFFAOYSA-N methanesulfonic anhydride Chemical compound CS(=O)(=O)OS(C)(=O)=O IZDROVVXIHRYMH-UHFFFAOYSA-N 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000012453 solvate Substances 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 6
- OUDFNZMQXZILJD-UHFFFAOYSA-N 5-methyl-2-furaldehyde Chemical compound CC1=CC=C(C=O)O1 OUDFNZMQXZILJD-UHFFFAOYSA-N 0.000 description 5
- 229910015900 BF3 Inorganic materials 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 5
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Chemical compound [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000013058 crude material Substances 0.000 description 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- 235000010446 mineral oil Nutrition 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229960003975 potassium Drugs 0.000 description 5
- 235000007686 potassium Nutrition 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 150000003333 secondary alcohols Chemical class 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- ZXQBECTXVXNCND-UHFFFAOYSA-N 2-iodo-4-methyl-1,3-thiazole Chemical compound CC1=CSC(I)=N1 ZXQBECTXVXNCND-UHFFFAOYSA-N 0.000 description 4
- ABWZRAHDTLHUII-UHFFFAOYSA-N 3,5,9-triazatricyclo[7.5.0.02,7]tetradeca-1,13-diene-4,6-dione Chemical compound N1C(NC(C2C1=C1N(CCCC=C1)C2)=O)=O ABWZRAHDTLHUII-UHFFFAOYSA-N 0.000 description 4
- CHSMEYAHRFTDFX-UHFFFAOYSA-N 3-(hydroxymethyl)-2h-furan-5-one Chemical compound OCC1=CC(=O)OC1 CHSMEYAHRFTDFX-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- ICMAFTSLXCXHRK-UHFFFAOYSA-N Ethyl pentanoate Chemical compound CCCCC(=O)OCC ICMAFTSLXCXHRK-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 125000005594 diketone group Chemical group 0.000 description 4
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 4
- 229940113088 dimethylacetamide Drugs 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 230000005496 eutectics Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 235000001055 magnesium Nutrition 0.000 description 4
- LVKCSZQWLOVUGB-UHFFFAOYSA-M magnesium;propane;bromide Chemical compound [Mg+2].[Br-].C[CH-]C LVKCSZQWLOVUGB-UHFFFAOYSA-M 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229940098779 methanesulfonic acid Drugs 0.000 description 4
- 239000012038 nucleophile Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 229920000137 polyphosphoric acid Polymers 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- PZPGNMUMILSRSX-UHFFFAOYSA-N tributyl-(4-methyl-1,3-thiazol-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=NC(C)=CS1 PZPGNMUMILSRSX-UHFFFAOYSA-N 0.000 description 4
- 238000002424 x-ray crystallography Methods 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- RKWWASUTWAFKHA-UHFFFAOYSA-N 1-bromo-2,3-difluorobenzene Chemical compound FC1=CC=CC(Br)=C1F RKWWASUTWAFKHA-UHFFFAOYSA-N 0.000 description 3
- HCSVUQJBRBZQSY-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-5-[4-(hydroxymethyl)-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3OC(Cl)=CC=3)SCCN2C=1C1=NC(CO)=CS1 HCSVUQJBRBZQSY-UHFFFAOYSA-N 0.000 description 3
- 238000004293 19F NMR spectroscopy Methods 0.000 description 3
- JYWKEVKEKOTYEX-UHFFFAOYSA-N 2,6-dibromo-4-chloroiminocyclohexa-2,5-dien-1-one Chemical compound ClN=C1C=C(Br)C(=O)C(Br)=C1 JYWKEVKEKOTYEX-UHFFFAOYSA-N 0.000 description 3
- MTEZLAATISORQK-UHFFFAOYSA-N 2-methoxyacetamide Chemical compound COCC(N)=O MTEZLAATISORQK-UHFFFAOYSA-N 0.000 description 3
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 3
- KUZXQXCWRNFIHK-UHFFFAOYSA-N 3,3-diethyldodecane Chemical compound CCCCCCCCCC(CC)(CC)CC KUZXQXCWRNFIHK-UHFFFAOYSA-N 0.000 description 3
- STXAVEHFKAXGOX-UHFFFAOYSA-N 3-bromobenzonitrile Chemical compound BrC1=CC=CC(C#N)=C1 STXAVEHFKAXGOX-UHFFFAOYSA-N 0.000 description 3
- OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 3
- SXADRSGCJKGVPU-UHFFFAOYSA-N 5-(3-fluorophenyl)-1,3-dimethyl-6h-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=CNC=1C1=CC=CC(F)=C1 SXADRSGCJKGVPU-UHFFFAOYSA-N 0.000 description 3
- NLJLQGFTHGMUOF-UHFFFAOYSA-N 7-[(4-chloro-1,3-thiazol-2-yl)-hydroxymethyl]-5-(3-fluorophenyl)-1,3-dimethyl-6h-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C(C(O)C=2SC=C(Cl)N=2)NC=1C1=CC=CC(F)=C1 NLJLQGFTHGMUOF-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 3
- UUIQMZJEGPQKFD-UHFFFAOYSA-N Methyl butyrate Chemical compound CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 3
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 3
- 101150003085 Pdcl gene Proteins 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 150000008359 benzonitriles Chemical class 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- LZWLLMFYVGUUAL-UHFFFAOYSA-L ditert-butyl(cyclopenta-1,3-dien-1-yl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1.CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1 LZWLLMFYVGUUAL-UHFFFAOYSA-L 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical class OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 150000004677 hydrates Chemical class 0.000 description 3
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 3
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
- 229940017219 methyl propionate Drugs 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 3
- 229960005141 piperazine Drugs 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DUYAAUVXQSMXQP-UHFFFAOYSA-M thioacetate Chemical compound CC([S-])=O DUYAAUVXQSMXQP-UHFFFAOYSA-M 0.000 description 3
- JPJIEXKLJOWQQK-UHFFFAOYSA-K trifluoromethanesulfonate;yttrium(3+) Chemical compound [Y+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F JPJIEXKLJOWQQK-UHFFFAOYSA-K 0.000 description 3
- GIIYCENPYHKOTP-UHFFFAOYSA-N (2,2-dimethyl-1,3-dioxolan-4-yl)methyl trifluoromethanesulfonate Chemical compound CC1(C)OCC(COS(=O)(=O)C(F)(F)F)O1 GIIYCENPYHKOTP-UHFFFAOYSA-N 0.000 description 2
- QXIOIUVTCYVNKA-LBPRGKRZSA-N (2s)-2-(1,3-dimethyl-2,4-dioxo-5-phenylpyrrolo[3,4-d]pyrimidin-6-yl)pentanedioic acid Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=CN([C@@H](CCC(O)=O)C(O)=O)C=1C1=CC=CC=C1 QXIOIUVTCYVNKA-LBPRGKRZSA-N 0.000 description 2
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- GRDXZRWCQWDLPG-UHFFFAOYSA-N 1,3,6-trimethylpyrimidine-2,4-dione Chemical compound CC1=CC(=O)N(C)C(=O)N1C GRDXZRWCQWDLPG-UHFFFAOYSA-N 0.000 description 2
- FVSHZKMTAADDOV-UHFFFAOYSA-N 1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-6H-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=CN2)=N1 FVSHZKMTAADDOV-UHFFFAOYSA-N 0.000 description 2
- QEAAHPHASHXUGR-UHFFFAOYSA-N 1,3-dimethyl-5-phenyl-6-(2-tritylsulfanylethyl)pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=1C=CC=CC=1C1=C2C(=O)N(C)C(=O)N(C)C2=CN1CCSC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 QEAAHPHASHXUGR-UHFFFAOYSA-N 0.000 description 2
- LOZWAPSEEHRYPG-UHFFFAOYSA-N 1,4-dithiane Chemical compound C1CSCCS1 LOZWAPSEEHRYPG-UHFFFAOYSA-N 0.000 description 2
- GSDMOPNVGUJQMT-UHFFFAOYSA-N 1,6-dihydropyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)NC2=CNC=C21 GSDMOPNVGUJQMT-UHFFFAOYSA-N 0.000 description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- AWNXKZVIZARMME-UHFFFAOYSA-N 1-[[5-[2-[(2-chloropyridin-4-yl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol Chemical compound N=1C(NCC(C)(O)C)=NC=C(C=2N=C(NC=3C=C(Cl)N=CC=3)N=CC=2)C=1CC1CC1 AWNXKZVIZARMME-UHFFFAOYSA-N 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 2
- PRBQGTHTOUQDAT-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(1-methylpyrazol-3-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CN1C=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SCCN32)=N1 PRBQGTHTOUQDAT-UHFFFAOYSA-N 0.000 description 2
- QNTGLAAAZRVNMY-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-8-(imidazol-1-ylmethyl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SC(CN4C=NC=C4)CN32)=N1 QNTGLAAAZRVNMY-UHFFFAOYSA-N 0.000 description 2
- QWWVSLBMMUDNTB-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methoxymethyl]oxirane Chemical compound C1=CC(OC)=CC=C1COCC1OC1 QWWVSLBMMUDNTB-UHFFFAOYSA-N 0.000 description 2
- SVDDJQGVOFZBNX-UHFFFAOYSA-N 2-chloroethyl carbonochloridate Chemical compound ClCCOC(Cl)=O SVDDJQGVOFZBNX-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 description 2
- XYVMOLOUBJBNBF-UHFFFAOYSA-N 3h-1,3-oxazol-2-one Chemical compound OC1=NC=CO1 XYVMOLOUBJBNBF-UHFFFAOYSA-N 0.000 description 2
- PVQRPRXBBGDUMX-UHFFFAOYSA-N 4-(hydroxymethyl)oxolan-2-one Chemical compound OCC1COC(=O)C1 PVQRPRXBBGDUMX-UHFFFAOYSA-N 0.000 description 2
- QMHIMXFNBOYPND-UHFFFAOYSA-N 4MTO Natural products CC1=CSC=N1 QMHIMXFNBOYPND-UHFFFAOYSA-N 0.000 description 2
- QQMPURPLRGBHNA-UHFFFAOYSA-N 6-(2,3-dihydroxypropyl)-5-(3-fluorophenyl)-1,3-dimethylpyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=CN(CC(O)CO)C=1C1=CC=CC(F)=C1 QQMPURPLRGBHNA-UHFFFAOYSA-N 0.000 description 2
- WJFZZIGYRAIAEE-UHFFFAOYSA-N 6-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]-5-(3-fluorophenyl)-1,3-dimethylpyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=1C=CC(F)=CC=1C1=C2C(=O)N(C)C(=O)N(C)C2=CN1CC1COC(C)(C)O1 WJFZZIGYRAIAEE-UHFFFAOYSA-N 0.000 description 2
- BYBGMWQVWNABGX-PMERELPUSA-N 6-[(2s)-1-hydroxy-3-tritylsulfanylpropan-2-yl]-1,3-dimethyl-5-phenylpyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C([C@H](CO)N1C=C2N(C(N(C)C(=O)C2=C1C=1C=CC=CC=1)=O)C)SC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 BYBGMWQVWNABGX-PMERELPUSA-N 0.000 description 2
- AUFHTJGHHXPMNI-UHFFFAOYSA-N 7-[(4-chloro-1,3-thiazol-2-yl)-hydroxymethyl]-1,3-dimethyl-5-phenyl-6h-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C(C(O)C=2SC=C(Cl)N=2)NC=1C1=CC=CC=C1 AUFHTJGHHXPMNI-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- ZSDLISYGWYYKRE-UHFFFAOYSA-N CC(C)(C)CCCCCCCCCCCOCN1C=C2C(=C1C3=CC(=CC=C3)F)C(=O)N(C(=O)N2C)C Chemical compound CC(C)(C)CCCCCCCCCCCOCN1C=C2C(=C1C3=CC(=CC=C3)F)C(=O)N(C(=O)N2C)C ZSDLISYGWYYKRE-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 2
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 238000005863 Friedel-Crafts acylation reaction Methods 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229910003803 Gold(III) chloride Inorganic materials 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- MGJKQDOBUOMPEZ-UHFFFAOYSA-N N,N'-dimethylurea Chemical compound CNC(=O)NC MGJKQDOBUOMPEZ-UHFFFAOYSA-N 0.000 description 2
- GSCCALZHGUWNJW-UHFFFAOYSA-N N-Cyclohexyl-N-methylcyclohexanamine Chemical compound C1CCCCC1N(C)C1CCCCC1 GSCCALZHGUWNJW-UHFFFAOYSA-N 0.000 description 2
- 238000007126 N-alkylation reaction Methods 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical group [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- NZHXEWZGTQSYJM-UHFFFAOYSA-N [bromo(diphenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Br)C1=CC=CC=C1 NZHXEWZGTQSYJM-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 2
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 2
- RXUBZLMIGSAPEJ-UHFFFAOYSA-N benzyl n-aminocarbamate Chemical compound NNC(=O)OCC1=CC=CC=C1 RXUBZLMIGSAPEJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000002648 combination therapy Methods 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- ZOCHARZZJNPSEU-UHFFFAOYSA-N diboron Chemical compound B#B ZOCHARZZJNPSEU-UHFFFAOYSA-N 0.000 description 2
- RJYMRRJVDRJMJW-UHFFFAOYSA-L dibromomanganese Chemical compound Br[Mn]Br RJYMRRJVDRJMJW-UHFFFAOYSA-L 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 2
- 229940043264 dodecyl sulfate Drugs 0.000 description 2
- 239000012039 electrophile Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- AFAXGSQYZLGZPG-UHFFFAOYSA-L ethane-1,2-disulfonate Chemical compound [O-]S(=O)(=O)CCS([O-])(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-L 0.000 description 2
- XDOKFEJMEJKVGX-UHFFFAOYSA-N ethyl 1,3-thiazole-4-carboxylate Chemical compound CCOC(=O)C1=CSC=N1 XDOKFEJMEJKVGX-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940050410 gluconate Drugs 0.000 description 2
- 229940097042 glucuronate Drugs 0.000 description 2
- RJHLTVSLYWWTEF-UHFFFAOYSA-K gold trichloride Chemical compound Cl[Au](Cl)Cl RJHLTVSLYWWTEF-UHFFFAOYSA-K 0.000 description 2
- CBMIPXHVOVTTTL-UHFFFAOYSA-N gold(3+) Chemical compound [Au+3] CBMIPXHVOVTTTL-UHFFFAOYSA-N 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 239000003701 inert diluent Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- 229940099584 lactobionate Drugs 0.000 description 2
- JYTUSYBCFIZPBE-AMTLMPIISA-M lactobionate Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-M 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 2
- 229960001571 loperamide Drugs 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229940049920 malate Drugs 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 2
- 229960003194 meglumine Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 2
- RLKHFSNWQCZBDC-UHFFFAOYSA-N n-(benzenesulfonyl)-n-fluorobenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(F)S(=O)(=O)C1=CC=CC=C1 RLKHFSNWQCZBDC-UHFFFAOYSA-N 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-M octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 238000012402 patch clamp technique Methods 0.000 description 2
- 235000019371 penicillin G benzathine Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000002600 positron emission tomography Methods 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- ZGJADVGJIVEEGF-UHFFFAOYSA-M potassium;phenoxide Chemical compound [K+].[O-]C1=CC=CC=C1 ZGJADVGJIVEEGF-UHFFFAOYSA-M 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 2
- 150000003233 pyrroles Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- ARSLWGHFZUGJTK-UHFFFAOYSA-K ruthenium(3+);trifluoromethanesulfonate Chemical compound [Ru+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F ARSLWGHFZUGJTK-UHFFFAOYSA-K 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000002603 single-photon emission computed tomography Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- NODRNSUBQQBWEJ-CQSZACIVSA-N (10r)-10-(4-chloro-1,3-thiazol-2-yl)-5-[4-(hydroxymethyl)-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S([C@H](C1=C2N(C(N(C)C(=O)C2=2)=O)C)C=3SC=C(Cl)N=3)CCN1C=2C1=NC(CO)=CS1 NODRNSUBQQBWEJ-CQSZACIVSA-N 0.000 description 1
- PRBQGTHTOUQDAT-KRWDZBQOSA-N (10r)-10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(1-methylpyrazol-3-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CN1C=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)SCCN32)=N1 PRBQGTHTOUQDAT-KRWDZBQOSA-N 0.000 description 1
- HODVQYQNLRXFNK-HNNXBMFYSA-N (10r)-10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound O1C(C)=NN=C1C1=C2C(=O)N(C)C(=O)N(C)C2=C2[C@H](C=3OC(Cl)=CC=3)SCCN21 HODVQYQNLRXFNK-HNNXBMFYSA-N 0.000 description 1
- BBKGYGFXPBKJAB-NRFANRHFSA-N (10r)-10-(5-chlorofuran-2-yl)-5-(3-ethoxyphenyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CCOC1=CC=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)SCCN32)=C1 BBKGYGFXPBKJAB-NRFANRHFSA-N 0.000 description 1
- HCSVUQJBRBZQSY-INIZCTEOSA-N (10r)-10-(5-chlorofuran-2-yl)-5-[4-(hydroxymethyl)-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S([C@H](C1=C2N(C(N(C)C(=O)C2=2)=O)C)C=3OC(Cl)=CC=3)CCN1C=2C1=NC(CO)=CS1 HCSVUQJBRBZQSY-INIZCTEOSA-N 0.000 description 1
- LZVAAXNDLUJMFY-XLFHBGCDSA-N (10r)-10-(5-chlorofuran-2-yl)-5-[4-[(1r)-1-hydroxyethyl]-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C[C@@H](O)C1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)SCCN32)=N1 LZVAAXNDLUJMFY-XLFHBGCDSA-N 0.000 description 1
- LZVAAXNDLUJMFY-XYZCENFISA-N (10r)-10-(5-chlorofuran-2-yl)-5-[4-[(1s)-1-hydroxyethyl]-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C[C@H](O)C1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)SCCN32)=N1 LZVAAXNDLUJMFY-XYZCENFISA-N 0.000 description 1
- HODVQYQNLRXFNK-OAHLLOKOSA-N (10s)-10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound O1C(C)=NN=C1C1=C2C(=O)N(C)C(=O)N(C)C2=C2[C@@H](C=3OC(Cl)=CC=3)SCCN21 HODVQYQNLRXFNK-OAHLLOKOSA-N 0.000 description 1
- LZVAAXNDLUJMFY-VVVCHXIZSA-N (10s)-10-(5-chlorofuran-2-yl)-5-[4-[(1r)-1-hydroxyethyl]-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C[C@@H](O)C1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@@H](C=4OC(Cl)=CC=4)SCCN32)=N1 LZVAAXNDLUJMFY-VVVCHXIZSA-N 0.000 description 1
- LZVAAXNDLUJMFY-HUTHGQBESA-N (10s)-10-(5-chlorofuran-2-yl)-5-[4-[(1s)-1-hydroxyethyl]-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C[C@H](O)C1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@@H](C=4OC(Cl)=CC=4)SCCN32)=N1 LZVAAXNDLUJMFY-HUTHGQBESA-N 0.000 description 1
- KBXXSTGPDJDKPZ-MRXNPFEDSA-N (11r)-1,3-dimethyl-11-(4-methyl-1,3-thiazol-2-yl)-5-phenyl-8,9,10,11-tetrahydro-7h-pyrimido[1,2]pyrrolo[4,5-a]azepine-2,4-dione Chemical compound CC1=CSC([C@H]2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)CCCC2)=N1 KBXXSTGPDJDKPZ-MRXNPFEDSA-N 0.000 description 1
- AQBHPGUVTLTFHL-AWEZNQCLSA-N (11s)-11-(4-chloro-1,3-thiazol-2-yl)-1,3-dimethyl-5-phenyl-8,9,10,11-tetrahydro-7h-pyrimido[1,2]pyrrolo[4,5-a]azepine-2,4-dione Chemical compound C([C@@H](C1=C2N(C(N(C)C(=O)C2=2)=O)C)C=3SC=C(Cl)N=3)CCCN1C=2C1=CC=CC=C1 AQBHPGUVTLTFHL-AWEZNQCLSA-N 0.000 description 1
- ZGVYRUCPMUAXAH-AWEZNQCLSA-N (11s)-11-(4-chloro-1,3-thiazol-2-yl)-5-(3-fluorophenyl)-1,3-dimethyl-8,9,10,11-tetrahydro-7h-pyrimido[1,2]pyrrolo[4,5-a]azepine-2,4-dione Chemical compound C([C@@H](C1=C2N(C(N(C)C(=O)C2=2)=O)C)C=3SC=C(Cl)N=3)CCCN1C=2C1=CC=CC(F)=C1 ZGVYRUCPMUAXAH-AWEZNQCLSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- ZBGBEDOUDIAIHO-NRFANRHFSA-N (2s)-2-amino-3-tritylsulfanylpropan-1-ol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(SC[C@H](CO)N)C1=CC=CC=C1 ZBGBEDOUDIAIHO-NRFANRHFSA-N 0.000 description 1
- XCVUSNMDBZZREY-UHFFFAOYSA-N (5-oxooxolan-3-yl)methyl trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OCC1COC(=O)C1 XCVUSNMDBZZREY-UHFFFAOYSA-N 0.000 description 1
- HGIIJMBAUDLRQN-MGNBDDOMSA-N (8r,10r)-10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(2-methyl-1,3-thiazol-4-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S1C(C)=NC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)S[C@@H](CO)CN32)=C1 HGIIJMBAUDLRQN-MGNBDDOMSA-N 0.000 description 1
- DBMBAPUQYZUKHG-QGHHPUGFSA-N (8r,10r)-10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)S[C@@H](CO)CN32)=N1 DBMBAPUQYZUKHG-QGHHPUGFSA-N 0.000 description 1
- GGKFHMXFNJQQFD-QRQCRPRQSA-N (8r,10r)-10-(5-chlorofuran-2-yl)-8-[(dimethylamino)methyl]-1,3-dimethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C1([C@H]2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)C[C@H](S2)CN(C)C)=CC=C(Cl)O1 GGKFHMXFNJQQFD-QRQCRPRQSA-N 0.000 description 1
- ZDZJVAUPWBWYOE-QGHHPUGFSA-N (8r,10r)-8-(aminomethyl)-10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)S[C@H](CN)CN32)=N1 ZDZJVAUPWBWYOE-QGHHPUGFSA-N 0.000 description 1
- YYMSODGVZHNXDE-XIKOKIGWSA-N (8r,10s)-10-(4-chloro-1,3-thiazol-2-yl)-5-(3-fluorophenyl)-8-(hydroxymethyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C([C@H](CO)S[C@@H](C1=C2N(C(N(C)C(=O)C2=2)=O)C)C=3SC=C(Cl)N=3)N1C=2C1=CC=CC(F)=C1 YYMSODGVZHNXDE-XIKOKIGWSA-N 0.000 description 1
- YILZNBNKEXAKMX-HXPMCKFVSA-N (8r,10s)-10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8-[(2-oxo-1,3-oxazolidin-3-yl)methyl]-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@@H](C=4OC(Cl)=CC=4)S[C@@H](CN4C(OCC4)=O)CN32)=N1 YILZNBNKEXAKMX-HXPMCKFVSA-N 0.000 description 1
- TWGOCEGNFPCVSG-ZUOKHONESA-N (8r,10s)-10-(5-chlorofuran-2-yl)-5-(3-fluorophenyl)-8-(hydroxymethyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C([C@H](CO)S[C@@H](C1=C2N(C(N(C)C(=O)C2=2)=O)C)C=3OC(Cl)=CC=3)N1C=2C1=CC=CC(F)=C1 TWGOCEGNFPCVSG-ZUOKHONESA-N 0.000 description 1
- ULTQGYQOQUFXDC-MLCYQJTMSA-N (8r,10s)-10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(1-methylpyrazol-3-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CN1C=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@@H](C=4OC(Cl)=CC=4)S[C@@H](CO)CN32)=N1 ULTQGYQOQUFXDC-MLCYQJTMSA-N 0.000 description 1
- HGIIJMBAUDLRQN-MLCYQJTMSA-N (8r,10s)-10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(2-methyl-1,3-thiazol-4-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S1C(C)=NC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@@H](C=4OC(Cl)=CC=4)S[C@@H](CO)CN32)=C1 HGIIJMBAUDLRQN-MLCYQJTMSA-N 0.000 description 1
- DBMBAPUQYZUKHG-BMLIUANNSA-N (8r,10s)-10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@@H](C=4OC(Cl)=CC=4)S[C@@H](CO)CN32)=N1 DBMBAPUQYZUKHG-BMLIUANNSA-N 0.000 description 1
- GGKFHMXFNJQQFD-IVZQSRNASA-N (8r,10s)-10-(5-chlorofuran-2-yl)-8-[(dimethylamino)methyl]-1,3-dimethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C1([C@@H]2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)C[C@H](S2)CN(C)C)=CC=C(Cl)O1 GGKFHMXFNJQQFD-IVZQSRNASA-N 0.000 description 1
- YYMSODGVZHNXDE-KPZWWZAWSA-N (8s,10r)-10-(4-chloro-1,3-thiazol-2-yl)-5-(3-fluorophenyl)-8-(hydroxymethyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C([C@@H](CO)S[C@H](C1=C2N(C(N(C)C(=O)C2=2)=O)C)C=3SC=C(Cl)N=3)N1C=2C1=CC=CC(F)=C1 YYMSODGVZHNXDE-KPZWWZAWSA-N 0.000 description 1
- DBMBAPUQYZUKHG-BTDLBPIBSA-N (8s,10r)-10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)S[C@H](CO)CN32)=N1 DBMBAPUQYZUKHG-BTDLBPIBSA-N 0.000 description 1
- GGKFHMXFNJQQFD-NYHFZMIOSA-N (8s,10r)-10-(5-chlorofuran-2-yl)-8-[(dimethylamino)methyl]-1,3-dimethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C1([C@H]2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)C[C@@H](S2)CN(C)C)=CC=C(Cl)O1 GGKFHMXFNJQQFD-NYHFZMIOSA-N 0.000 description 1
- ZDZJVAUPWBWYOE-BTDLBPIBSA-N (8s,10r)-8-(aminomethyl)-10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@H](C=4OC(Cl)=CC=4)S[C@@H](CN)CN32)=N1 ZDZJVAUPWBWYOE-BTDLBPIBSA-N 0.000 description 1
- TWGOCEGNFPCVSG-RNODOKPDSA-N (8s,10s)-10-(5-chlorofuran-2-yl)-5-(3-fluorophenyl)-8-(hydroxymethyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C([C@@H](CO)S[C@@H](C1=C2N(C(N(C)C(=O)C2=2)=O)C)C=3OC(Cl)=CC=3)N1C=2C1=CC=CC(F)=C1 TWGOCEGNFPCVSG-RNODOKPDSA-N 0.000 description 1
- ULTQGYQOQUFXDC-XTZNXHDOSA-N (8s,10s)-10-(5-chlorofuran-2-yl)-8-(hydroxymethyl)-1,3-dimethyl-5-(1-methylpyrazol-3-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CN1C=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@@H](C=4OC(Cl)=CC=4)S[C@H](CO)CN32)=N1 ULTQGYQOQUFXDC-XTZNXHDOSA-N 0.000 description 1
- ZDZJVAUPWBWYOE-DYZYQPBXSA-N (8s,10s)-8-(aminomethyl)-10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3[C@@H](C=4OC(Cl)=CC=4)S[C@@H](CN)CN32)=N1 ZDZJVAUPWBWYOE-DYZYQPBXSA-N 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- FCDNVZVJKPOBNM-UHFFFAOYSA-N 1,3-dimethyl-10-(3-methylphenyl)-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CC=CC(C2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)CCS2)=C1 FCDNVZVJKPOBNM-UHFFFAOYSA-N 0.000 description 1
- AFVJCJCIBVZUIV-UHFFFAOYSA-N 1,3-dimethyl-10-(4-methyl-1,3-thiazol-2-yl)-5-phenyl-7,8-dihydropyrimido[1,2]pyrrolo[4,5-b]pyridazine-2,4-dione Chemical compound CC1=CSC(C=2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)NCC=2)=N1 AFVJCJCIBVZUIV-UHFFFAOYSA-N 0.000 description 1
- OWDSPKZXDBSXBH-UHFFFAOYSA-N 1,3-dimethyl-10-(4-methyl-1,3-thiazol-2-yl)-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)CCS2)=N1 OWDSPKZXDBSXBH-UHFFFAOYSA-N 0.000 description 1
- OASYIEDNYIVIDV-UHFFFAOYSA-N 1,3-dimethyl-10-(4-methylthiophen-2-yl)-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=CC=CC=3)CCS2)=C1 OASYIEDNYIVIDV-UHFFFAOYSA-N 0.000 description 1
- SFMJYXVKTHMZBI-UHFFFAOYSA-N 1,3-dimethyl-10-(5-methylfuran-2-yl)-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound O1C(C)=CC=C1C1C2=C(N(C)C(=O)N(C)C3=O)C3=C(C=3C=CC=CC=3)N2CCS1 SFMJYXVKTHMZBI-UHFFFAOYSA-N 0.000 description 1
- HJIGONFSKHXHOO-UHFFFAOYSA-N 1,3-dimethyl-5-(1-methylpyrazol-3-yl)-6H-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound CN1C=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=CN2)=N1 HJIGONFSKHXHOO-UHFFFAOYSA-N 0.000 description 1
- PYTIQBNISILIGV-UHFFFAOYSA-N 1,3-dimethyl-5-(3-methylphenyl)-10-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2C=3N(C(=C4C(=O)N(C)C(=O)N(C)C4=3)C=3C=C(C)C=CC=3)CCS2)=N1 PYTIQBNISILIGV-UHFFFAOYSA-N 0.000 description 1
- RCHIQXBEYZZUSG-UHFFFAOYSA-N 1,3-dimethyl-5-phenyl-8,9-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-b]pyridazine-2,4,10-trione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(=O)CCNN2C=1C1=CC=CC=C1 RCHIQXBEYZZUSG-UHFFFAOYSA-N 0.000 description 1
- MNPOFAXKBZPGNK-UHFFFAOYSA-N 1,3-dimethyl-6h-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)N(C)C2=CNC=C21 MNPOFAXKBZPGNK-UHFFFAOYSA-N 0.000 description 1
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- IMLSAISZLJGWPP-UHFFFAOYSA-N 1,3-dithiolane Chemical compound C1CSCS1 IMLSAISZLJGWPP-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- DBQCLCUSGVYCJA-UHFFFAOYSA-N 1-[(3-chloro-2-tritylsulfanylpropoxy)methyl]-4-methoxybenzene Chemical compound C1=CC(OC)=CC=C1COCC(CCl)SC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 DBQCLCUSGVYCJA-UHFFFAOYSA-N 0.000 description 1
- QDFKKJYEIFBEFC-UHFFFAOYSA-N 1-bromo-3-fluorobenzene Chemical compound FC1=CC=CC(Br)=C1 QDFKKJYEIFBEFC-UHFFFAOYSA-N 0.000 description 1
- ACNQJGLSENYFQJ-UHFFFAOYSA-N 1-chloro-3-(dichloromethyl)benzene Chemical compound ClC(Cl)C1=CC=CC(Cl)=C1 ACNQJGLSENYFQJ-UHFFFAOYSA-N 0.000 description 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
- HHHSZBNXXGKYHH-UHFFFAOYSA-N 1-methoxy-2-methylprop-1-ene Chemical compound COC=C(C)C HHHSZBNXXGKYHH-UHFFFAOYSA-N 0.000 description 1
- GUBNFBYCBZWEES-UHFFFAOYSA-N 1-methylsulfonylpentane Chemical group CCCCCS(C)(=O)=O GUBNFBYCBZWEES-UHFFFAOYSA-N 0.000 description 1
- NLOPRZWYUAFUFX-UHFFFAOYSA-N 10-(2-chloro-1,3-thiazol-4-yl)-1,3-dimethyl-5-(1-methylpyrazol-3-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CN1C=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4N=C(Cl)SC=4)SCCN32)=N1 NLOPRZWYUAFUFX-UHFFFAOYSA-N 0.000 description 1
- NJDHRJPRGCUZCW-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3,8-trimethyl-5-phenyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound S1C(C)CN(C(=C2C(=O)N(C)C(=O)N(C)C2=2)C=3C=CC=CC=3)C=2C1C1=CC=C(Cl)O1 NJDHRJPRGCUZCW-UHFFFAOYSA-N 0.000 description 1
- JUUGCRVAKZXRJJ-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(4-methyl-1,3-oxazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=COC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SCCN32)=N1 JUUGCRVAKZXRJJ-UHFFFAOYSA-N 0.000 description 1
- TWGOCEGNFPCVSG-UHFFFAOYSA-N 10-(5-chlorofuran-2-yl)-5-(3-fluorophenyl)-8-(hydroxymethyl)-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C2C(C=3OC(Cl)=CC=3)SC(CO)CN2C=1C1=CC=CC(F)=C1 TWGOCEGNFPCVSG-UHFFFAOYSA-N 0.000 description 1
- LZVAAXNDLUJMFY-WFVOFKTRSA-N 10-(5-chlorofuran-2-yl)-5-[4-[(1s)-1-hydroxyethyl]-1,3-thiazol-2-yl]-1,3-dimethyl-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound C[C@H](O)C1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SCCN32)=N1 LZVAAXNDLUJMFY-WFVOFKTRSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- IURVWNHHAAQFIE-UHFFFAOYSA-N 1H-pyrrolo[1,2-b]pyridazine-2,4-dione Chemical compound N1N2C(C(CC1=O)=O)=CC=C2 IURVWNHHAAQFIE-UHFFFAOYSA-N 0.000 description 1
- YNCPXBIZAPNQIJ-UHFFFAOYSA-N 1h-imidazole;sodium Chemical compound [Na].C1=CNC=N1 YNCPXBIZAPNQIJ-UHFFFAOYSA-N 0.000 description 1
- PIZHFBODNLEQBL-UHFFFAOYSA-N 2,2-diethoxy-1-phenylethanone Chemical compound CCOC(OCC)C(=O)C1=CC=CC=C1 PIZHFBODNLEQBL-UHFFFAOYSA-N 0.000 description 1
- 125000003562 2,2-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- CLGVOZPMWDEZCD-UHFFFAOYSA-N 2,3-dihydroxy-2,3-bis(sulfanyl)butanedioic acid Chemical compound SC(C(C(=O)O)(O)S)(O)C(=O)O CLGVOZPMWDEZCD-UHFFFAOYSA-N 0.000 description 1
- 125000003660 2,3-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- XQBXADARQLPYNQ-UHFFFAOYSA-N 2-(3-bromo-2-tritylsulfanylpropyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(CBr)SC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XQBXADARQLPYNQ-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- DUILGEYLVHGSEE-UHFFFAOYSA-N 2-(oxiran-2-ylmethyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1CO1 DUILGEYLVHGSEE-UHFFFAOYSA-N 0.000 description 1
- GTCCDZBQJAYKTO-UHFFFAOYSA-N 2-(thiiran-2-ylmethyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1CS1 GTCCDZBQJAYKTO-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 1
- UKJHPSSPNZTIHS-UHFFFAOYSA-N 2-benzhydryl-2,3-dihydroxybutanedioic acid Chemical compound C(C1=CC=CC=C1)(C1=CC=CC=C1)C(C(=O)O)(O)C(O)C(=O)O UKJHPSSPNZTIHS-UHFFFAOYSA-N 0.000 description 1
- VWGRESZTMULPDE-UHFFFAOYSA-N 2-bromo-5-methylfuran Chemical compound CC1=CC=C(Br)O1 VWGRESZTMULPDE-UHFFFAOYSA-N 0.000 description 1
- MXVMRHIWTSFDPU-UHFFFAOYSA-N 2-chlorobenzenecarboximidamide Chemical compound NC(=N)C1=CC=CC=C1Cl MXVMRHIWTSFDPU-UHFFFAOYSA-N 0.000 description 1
- LIJLYNWYKULUHA-UHFFFAOYSA-N 2-chloroethyl carbamate Chemical compound NC(=O)OCCCl LIJLYNWYKULUHA-UHFFFAOYSA-N 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- XZOWICPSVWHCTC-UHFFFAOYSA-N 2-tritylsulfanylethanamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(SCCN)C1=CC=CC=C1 XZOWICPSVWHCTC-UHFFFAOYSA-N 0.000 description 1
- BONPFXLOAPUHHF-UHFFFAOYSA-N 3-(1,3-dimethyl-2,4-dioxo-5-phenylpyrrolo[3,4-d]pyrimidin-6-yl)propanoic acid Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=CN(CCC(O)=O)C=1C1=CC=CC=C1 BONPFXLOAPUHHF-UHFFFAOYSA-N 0.000 description 1
- BQQDMFGWHDEOPL-UHFFFAOYSA-N 3-[(1,3-dimethyl-2,4-dioxo-5-phenylpyrrolo[3,4-d]pyrimidin-6-yl)-phenylmethoxycarbonylamino]propanoic acid Chemical compound C=1C=CC=CC=1C1=C2C(=O)N(C)C(=O)N(C)C2=CN1N(CCC(O)=O)C(=O)OCC1=CC=CC=C1 BQQDMFGWHDEOPL-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- SITJXRWLFQGWCB-UHFFFAOYSA-N 3-iodo-1-methylpyrazole Chemical group CN1C=CC(I)=N1 SITJXRWLFQGWCB-UHFFFAOYSA-N 0.000 description 1
- 125000003469 3-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- HOMUIRDLUGQYFH-UHFFFAOYSA-N 3h-pyrrolo[1,2-a]azepine Chemical compound C1=CC=CN2CC=CC2=C1 HOMUIRDLUGQYFH-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical compound [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 description 1
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-sulfosalicylic acid Chemical class OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 description 1
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
- QBDPDFHZUVBCQB-UHFFFAOYSA-N 6-(2,3-dihydroxypropyl)-1,3-dimethyl-5-phenylpyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=CN(CC(O)CO)C=1C1=CC=CC=C1 QBDPDFHZUVBCQB-UHFFFAOYSA-N 0.000 description 1
- LLHWSBXZXJXVPL-UHFFFAOYSA-N 6-(2-methylphenyl)-1,3,5-triazine-2,4-diamine Chemical compound CC1=CC=CC=C1C1=NC(N)=NC(N)=N1 LLHWSBXZXJXVPL-UHFFFAOYSA-N 0.000 description 1
- VTESKNPRXVULPX-UHFFFAOYSA-N 6-[3-(4-chloro-1,3-thiazol-2-yl)-3-hydroxypropyl]-1,3-dimethyl-5-phenylpyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=1C=CC=CC=1C1=C2C(=O)N(C)C(=O)N(C)C2=CN1CCC(O)C1=NC(Cl)=CS1 VTESKNPRXVULPX-UHFFFAOYSA-N 0.000 description 1
- RWSDXCVROIURMN-UHFFFAOYSA-N 6-[3-(4-chloro-1,3-thiazol-2-yl)-3-oxopropyl]-1,3-dimethyl-5-phenylpyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=1C=CC=CC=1C1=C2C(=O)N(C)C(=O)N(C)C2=CN1CCC(=O)C1=NC(Cl)=CS1 RWSDXCVROIURMN-UHFFFAOYSA-N 0.000 description 1
- RPABQMQOEJFCSQ-UHFFFAOYSA-N 6-[3-[(4-methoxyphenyl)methoxy]-2-tritylsulfanylpropyl]-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C1=CC(OC)=CC=C1COCC(SC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C=1C=CC=CC=1)CN1C(C=2SC=C(C)N=2)=C2C(=O)N(C)C(=O)N(C)C2=C1 RPABQMQOEJFCSQ-UHFFFAOYSA-N 0.000 description 1
- WCTRQKPMJXYMKQ-UHFFFAOYSA-N 6-[4-(4-chloro-1,3-thiazol-2-yl)-4-oxobutyl]-1,3-dimethyl-5-(1-methylpyrazol-3-yl)pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound CN1C=CC(C2=C3C(=O)N(C)C(=O)N(C)C3=CN2CCCC(=O)C=2SC=C(Cl)N=2)=N1 WCTRQKPMJXYMKQ-UHFFFAOYSA-N 0.000 description 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
- YTODWOKMOLRQFE-UHFFFAOYSA-N 7-[1-(4-chloro-1,3-thiazol-2-yl)-3,4-dihydroxybutyl]-5-(3-fluorophenyl)-1,3-dimethyl-6h-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C(C(CC(O)CO)C=2SC=C(Cl)N=2)NC=1C1=CC=CC(F)=C1 YTODWOKMOLRQFE-UHFFFAOYSA-N 0.000 description 1
- FWWMQDNNLYVPHP-UHFFFAOYSA-N 7-[1-(4-chloro-1,3-thiazol-2-yl)-3-hydroxy-2,2-dimethylpropyl]-1,3-dimethyl-5-phenyl-6h-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C(C(C=2SC=C(Cl)N=2)C(C)(C)CO)NC=1C1=CC=CC=C1 FWWMQDNNLYVPHP-UHFFFAOYSA-N 0.000 description 1
- HHXDHQDBWVVWGE-UHFFFAOYSA-N 7-[1-(4-chloro-1,3-thiazol-2-yl)-3-hydroxy-2-(hydroxymethyl)propyl]-5-(3-fluorophenyl)-1,3-dimethyl-6h-pyrrolo[3,4-d]pyrimidine-2,4-dione Chemical compound C=12C(=O)N(C)C(=O)N(C)C2=C(C(C(CO)CO)C=2SC=C(Cl)N=2)NC=1C1=CC=CC(F)=C1 HHXDHQDBWVVWGE-UHFFFAOYSA-N 0.000 description 1
- ZDZJVAUPWBWYOE-UHFFFAOYSA-N 8-(aminomethyl)-10-(5-chlorofuran-2-yl)-1,3-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-8,10-dihydro-7h-pyrimido[1,2]pyrrolo[4,5-a][1,4]thiazine-2,4-dione Chemical compound CC1=CSC(C2=C3C(=O)N(C)C(=O)N(C)C3=C3C(C=4OC(Cl)=CC=4)SC(CN)CN32)=N1 ZDZJVAUPWBWYOE-UHFFFAOYSA-N 0.000 description 1
- PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 101100096578 Arabidopsis thaliana SQD2 gene Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- ZEQWRSJQVHEPCG-UHFFFAOYSA-N C(CCC)C(C(Cl)(C)C)CCCCCCCC Chemical compound C(CCC)C(C(Cl)(C)C)CCCCCCCC ZEQWRSJQVHEPCG-UHFFFAOYSA-N 0.000 description 1
- LLZBCPCBVQVCRA-UHFFFAOYSA-N C(CCC)C1=C(C(=C(C=2CC3=CC=CC=C3C12)Cl)C)C Chemical compound C(CCC)C1=C(C(=C(C=2CC3=CC=CC=C3C12)Cl)C)C LLZBCPCBVQVCRA-UHFFFAOYSA-N 0.000 description 1
- SNLYUYUWEGSRRG-UHFFFAOYSA-N CC(C)(C)CCCCCCCCCCCOCN(C=C1C(N2C)=O)C=C1N(C)C2=O Chemical compound CC(C)(C)CCCCCCCCCCCOCN(C=C1C(N2C)=O)C=C1N(C)C2=O SNLYUYUWEGSRRG-UHFFFAOYSA-N 0.000 description 1
- RCLUMSVCQVXTAS-UHFFFAOYSA-N CC(C)(C)CCCCCCCCCCCOCN(C=C1N(C)C(N2C)=O)C(C3=CC=CC(C#N)=C3)=C1C2=O Chemical compound CC(C)(C)CCCCCCCCCCCOCN(C=C1N(C)C(N2C)=O)C(C3=CC=CC(C#N)=C3)=C1C2=O RCLUMSVCQVXTAS-UHFFFAOYSA-N 0.000 description 1
- FOWJAXYLXZOXDH-UHFFFAOYSA-N CC1(OC(C(OC1)(C)C)(C)C)C.[Na] Chemical compound CC1(OC(C(OC1)(C)C)(C)C)C.[Na] FOWJAXYLXZOXDH-UHFFFAOYSA-N 0.000 description 1
- VATXDNSYROGEDY-UHFFFAOYSA-N CC1=CN(C(=C1)C2=NC(=CS2)C)C Chemical compound CC1=CN(C(=C1)C2=NC(=CS2)C)C VATXDNSYROGEDY-UHFFFAOYSA-N 0.000 description 1
- NOKUGEHINIMBLO-UHFFFAOYSA-N CC1C(=CC2=CC=CC=C2)C(=O)N(C(=O)N1C)C Chemical compound CC1C(=CC2=CC=CC=C2)C(=O)N(C(=O)N1C)C NOKUGEHINIMBLO-UHFFFAOYSA-N 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- SLJSWEQETZKLDB-UHFFFAOYSA-N ClC1=C([C-](C=C1)P(C(C)(C)C)C(C)(C)C)Cl.[C-]1(C=CC=C1)P(C(C)(C)C)C(C)(C)C.[Fe+2] Chemical compound ClC1=C([C-](C=C1)P(C(C)(C)C)C(C)(C)C)Cl.[C-]1(C=CC=C1)P(C(C)(C)C)C(C)(C)C.[Fe+2] SLJSWEQETZKLDB-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 229930195710 D‐cysteine Natural products 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 238000007341 Heck reaction Methods 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910021568 Manganese(II) bromide Inorganic materials 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100189356 Mus musculus Papolb gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 241001061127 Thione Species 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 101150012828 UPC2 gene Proteins 0.000 description 1
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- PCBOWMZAEDDKNH-HOTGVXAUSA-N [4-(trifluoromethoxy)phenyl]methyl (3as,6as)-2-(3-fluoro-4-sulfamoylbenzoyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1=C(F)C(S(=O)(=O)N)=CC=C1C(=O)N1C[C@H]2CN(C(=O)OCC=3C=CC(OC(F)(F)F)=CC=3)C[C@@H]2C1 PCBOWMZAEDDKNH-HOTGVXAUSA-N 0.000 description 1
- DKUJZSSITBOYJD-UHFFFAOYSA-N [Cl-].BrCCCC[PH3+] Chemical group [Cl-].BrCCCC[PH3+] DKUJZSSITBOYJD-UHFFFAOYSA-N 0.000 description 1
- MJMXSNHYUJBWKG-UHFFFAOYSA-N [Cl-].[SH3+].C Chemical compound [Cl-].[SH3+].C MJMXSNHYUJBWKG-UHFFFAOYSA-N 0.000 description 1
- QVMHBCYOURAVBN-UHFFFAOYSA-L [Li+].[Cl-].CCC[Mg]Cl Chemical compound [Li+].[Cl-].CCC[Mg]Cl QVMHBCYOURAVBN-UHFFFAOYSA-L 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 238000005937 allylation reaction Methods 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125714 antidiarrheal agent Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical class N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 101150117004 atg18 gene Proteins 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- YOUGRGFIHBUKRS-UHFFFAOYSA-N benzyl(trimethyl)azanium Chemical compound C[N+](C)(C)CC1=CC=CC=C1 YOUGRGFIHBUKRS-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- NYENCOMLZDQKNH-UHFFFAOYSA-K bis(trifluoromethylsulfonyloxy)bismuthanyl trifluoromethanesulfonate Chemical compound [Bi+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F NYENCOMLZDQKNH-UHFFFAOYSA-K 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 1
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 1
- FAXNSSHWASVXKY-UHFFFAOYSA-M cesium;trifluoromethanesulfonate Chemical compound [Cs+].[O-]S(=O)(=O)C(F)(F)F FAXNSSHWASVXKY-UHFFFAOYSA-M 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003181 co-melting Methods 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 239000013066 combination product Substances 0.000 description 1
- 229940127555 combination product Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- GCUVBACNBHGZRS-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopenta-2,4-dien-1-yl(diphenyl)phosphane iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.c1cc[c-](c1)P(c1ccccc1)c1ccccc1 GCUVBACNBHGZRS-UHFFFAOYSA-N 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- YSSSPARMOAYJTE-UHFFFAOYSA-N dibenzo-18-crown-6 Chemical compound O1CCOCCOC2=CC=CC=C2OCCOCCOC2=CC=CC=C21 YSSSPARMOAYJTE-UHFFFAOYSA-N 0.000 description 1
- 125000006003 dichloroethyl group Chemical group 0.000 description 1
- 125000004774 dichlorofluoromethyl group Chemical group FC(Cl)(Cl)* 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 125000006001 difluoroethyl group Chemical group 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 238000005906 dihydroxylation reaction Methods 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- JNPDIGDNCHJQRP-UHFFFAOYSA-N dodec-1-en-1-one Chemical compound CCCCCCCCCCC=C=O JNPDIGDNCHJQRP-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 229940112141 dry powder inhaler Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000003372 electrophysiological method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- MJTBOJTZBTVRNH-UHFFFAOYSA-N ethyl 2-(6-diphenylphosphanylcyclohexa-2,4-dien-1-ylidene)acetate Chemical compound CCOC(=O)C=C1C=CC=CC1P(C=1C=CC=CC=1)C1=CC=CC=C1 MJTBOJTZBTVRNH-UHFFFAOYSA-N 0.000 description 1
- AFRWBGJRWRHQOV-UHFFFAOYSA-N ethyl 5-bromopentanoate Chemical compound CCOC(=O)CCCCBr AFRWBGJRWRHQOV-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012025 fluorinating agent Substances 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- DUJKMJZZYGMSQR-UHFFFAOYSA-N fluoromethylsulfonyl fluoromethanesulfonate Chemical compound FCS(=O)(=O)OS(=O)(=O)CF DUJKMJZZYGMSQR-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 125000006343 heptafluoro propyl group Chemical group 0.000 description 1
- QCIYAEYRVFUFAP-UHFFFAOYSA-N hexane-2,3-diol Chemical compound CCCC(O)C(C)O QCIYAEYRVFUFAP-UHFFFAOYSA-N 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XPGRZDJXVKFLHQ-UHFFFAOYSA-N hydron;methyl 3-aminopropanoate;chloride Chemical compound Cl.COC(=O)CCN XPGRZDJXVKFLHQ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 150000002641 lithium Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- DBTNVRCCIDISMV-UHFFFAOYSA-L lithium;magnesium;propane;dichloride Chemical compound [Li+].[Mg+2].[Cl-].[Cl-].C[CH-]C DBTNVRCCIDISMV-UHFFFAOYSA-L 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- QARBMVPHQWIHKH-KHWXYDKHSA-N methanesulfonyl chloride Chemical group C[35S](Cl)(=O)=O QARBMVPHQWIHKH-KHWXYDKHSA-N 0.000 description 1
- QAWFLJGZSZIZHO-UHFFFAOYSA-N methyl 4-bromobutanoate Chemical compound COC(=O)CCCBr QAWFLJGZSZIZHO-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- HWWVAHCWJLGKLW-UHFFFAOYSA-N n,n-dimethylhydroxylamine;hydron;chloride Chemical compound Cl.CN(C)O HWWVAHCWJLGKLW-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000018791 negative regulation of catalytic activity Effects 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- IVMHDOBGNQOUHO-UHFFFAOYSA-N oxathiane Chemical compound C1CCSOC1 IVMHDOBGNQOUHO-UHFFFAOYSA-N 0.000 description 1
- OOFGXDQWDNJDIS-UHFFFAOYSA-N oxathiolane Chemical compound C1COSC1 OOFGXDQWDNJDIS-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- CUQOHAYJWVTKDE-UHFFFAOYSA-N potassium;butan-1-olate Chemical compound [K+].CCCC[O-] CUQOHAYJWVTKDE-UHFFFAOYSA-N 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- CQBPOPVKDNHISM-UHFFFAOYSA-N propane-1,2,3-triol;propan-2-one Chemical compound CC(C)=O.OCC(O)CO CQBPOPVKDNHISM-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- KBJXDTIYSSQJAI-UHFFFAOYSA-N propylcarbamic acid Chemical compound CCCNC(O)=O KBJXDTIYSSQJAI-UHFFFAOYSA-N 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- JVANLUCASVHWEW-UHFFFAOYSA-N pyridazine Chemical compound N1=C=C=C=C=N1 JVANLUCASVHWEW-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229910001927 ruthenium tetroxide Inorganic materials 0.000 description 1
- VIHDTGHDWPVSMM-UHFFFAOYSA-N ruthenium;triphenylphosphane Chemical compound [Ru].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 VIHDTGHDWPVSMM-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 101150031442 sfc1 gene Proteins 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
- 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical class [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical compound [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 description 1
- 229910000080 stannane Inorganic materials 0.000 description 1
- 229940114926 stearate Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- MOOINZMWVOZBQO-UHFFFAOYSA-N sulfo 2-hydroxybenzoate Chemical compound OC1=CC=CC=C1C(=O)OS(O)(=O)=O MOOINZMWVOZBQO-UHFFFAOYSA-N 0.000 description 1
- 229940071103 sulfosalicylate Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- NYBWUHOMYZZKOR-UHFFFAOYSA-N tes-adt Chemical class C1=C2C(C#C[Si](CC)(CC)CC)=C(C=C3C(SC=C3)=C3)C3=C(C#C[Si](CC)(CC)CC)C2=CC2=C1SC=C2 NYBWUHOMYZZKOR-UHFFFAOYSA-N 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 238000009901 transfer hydrogenation reaction Methods 0.000 description 1
- YLGRTLMDMVAFNI-UHFFFAOYSA-N tributyl(prop-2-enyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)CC=C YLGRTLMDMVAFNI-UHFFFAOYSA-N 0.000 description 1
- OTMIHZHASCPXNT-UHFFFAOYSA-N tributyl-(5-methylfuran-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=C(C)O1 OTMIHZHASCPXNT-UHFFFAOYSA-N 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- AHZJKOKFZJYCLG-UHFFFAOYSA-K trifluoromethanesulfonate;ytterbium(3+) Chemical compound [Yb+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F AHZJKOKFZJYCLG-UHFFFAOYSA-K 0.000 description 1
- IIHPVYJPDKJYOU-UHFFFAOYSA-N triphenylcarbethoxymethylenephosphorane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OCC)C1=CC=CC=C1 IIHPVYJPDKJYOU-UHFFFAOYSA-N 0.000 description 1
- JQZIKLPHXXBMCA-UHFFFAOYSA-N triphenylmethanethiol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(S)C1=CC=CC=C1 JQZIKLPHXXBMCA-UHFFFAOYSA-N 0.000 description 1
- JUDXOKKZTISQDJ-UHFFFAOYSA-N triphenylphosphane;hydrochloride Chemical compound Cl.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 JUDXOKKZTISQDJ-UHFFFAOYSA-N 0.000 description 1
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 229950000339 xinafoate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261739335P | 2012-12-19 | 2012-12-19 | |
| US201361906141P | 2013-11-19 | 2013-11-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201429974A true TW201429974A (zh) | 2014-08-01 |
Family
ID=50030372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102147023A TW201429974A (zh) | 2012-12-19 | 2013-12-18 | 三環化合物 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20140171417A1 (https=) |
| EP (1) | EP2935278B1 (https=) |
| JP (1) | JP6284546B2 (https=) |
| KR (1) | KR20150097660A (https=) |
| CN (1) | CN105143230B (https=) |
| AP (1) | AP2015008539A0 (https=) |
| AR (1) | AR094122A1 (https=) |
| AU (1) | AU2013365739A1 (https=) |
| BR (1) | BR112015014292A2 (https=) |
| CA (1) | CA2895660A1 (https=) |
| CL (1) | CL2015001730A1 (https=) |
| CR (1) | CR20150325A (https=) |
| CU (1) | CU20150066A7 (https=) |
| EA (1) | EA201591177A1 (https=) |
| ES (1) | ES2628369T3 (https=) |
| HK (1) | HK1209741A1 (https=) |
| IL (1) | IL239389A0 (https=) |
| MX (1) | MX2015007939A (https=) |
| PE (1) | PE20151055A1 (https=) |
| PH (1) | PH12015501386A1 (https=) |
| SG (1) | SG11201504594QA (https=) |
| TN (1) | TN2015000279A1 (https=) |
| TW (1) | TW201429974A (https=) |
| UY (1) | UY35211A (https=) |
| WO (1) | WO2014097148A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9056867B2 (en) | 2011-09-16 | 2015-06-16 | Novartis Ag | N-substituted heterocyclyl carboxamides |
| AU2013365827A1 (en) | 2012-12-19 | 2015-07-09 | Novartis Ag | Tricyclic compounds as CFTR inhibitors |
| EA201591177A1 (ru) | 2012-12-19 | 2015-11-30 | Новартис Аг | Трициклические соединения для ингибирования канала cftr |
| TWI686429B (zh) | 2014-09-19 | 2020-03-01 | 美商摩曼帝夫特性材料公司 | 用於經控制之矽氧烷交聯的鉑(ii)二烯錯合物 |
| HUE054399T2 (hu) * | 2015-04-23 | 2021-09-28 | Trevi Therapeutics Inc | Vegyületek viszketéses állapotok kezelésére |
| CN106478558B (zh) * | 2016-10-17 | 2019-03-29 | 天津雅奥科技发展有限公司 | 一种4-羟甲基-二氢-呋喃-2(3h)-酮的合成方法 |
| US12319686B2 (en) | 2019-01-17 | 2025-06-03 | Hoffmann-La Roche Inc. | Process for the preparation of tetrahydropyridopyrimidines |
| BR112021025048A2 (pt) * | 2019-06-12 | 2022-02-01 | Univ California | Métodos de tratamento de diarreia por ácido biliar |
| EP4329815A1 (en) | 2021-04-29 | 2024-03-06 | Novartis AG | Deubiquitinase-targeting chimeras and related methods |
| CN117654560B (zh) * | 2023-12-01 | 2024-06-04 | 安徽泽升科技股份有限公司 | 一种通过氧化氨基连续化制备硝基化合物的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1207161B1 (en) | 1999-08-25 | 2006-01-18 | Banyu Pharmaceutical Co., Ltd. | Novel isoindole derivatives |
| JP2002255967A (ja) | 2001-02-27 | 2002-09-11 | Banyu Pharmaceut Co Ltd | イソインドール誘導体を有効成分とする糖尿病の治療剤、糖尿病の慢性合併症の予防剤又は肥満の治療剤。 |
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| AU2007332754A1 (en) | 2006-12-12 | 2008-06-19 | Schering Corporation | Aspartyl protease inhibitors |
| WO2009042270A2 (en) * | 2007-07-05 | 2009-04-02 | Trustees Of Boston University | Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| EP2464354B1 (en) * | 2009-08-10 | 2015-04-01 | The Regents of The University of California | Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor |
| WO2012166658A1 (en) * | 2011-05-27 | 2012-12-06 | The Regents Of The University Of California | Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor |
| AU2013365827A1 (en) | 2012-12-19 | 2015-07-09 | Novartis Ag | Tricyclic compounds as CFTR inhibitors |
| EA201591177A1 (ru) | 2012-12-19 | 2015-11-30 | Новартис Аг | Трициклические соединения для ингибирования канала cftr |
-
2013
- 2013-12-17 EA EA201591177A patent/EA201591177A1/ru unknown
- 2013-12-17 HK HK15110599.7A patent/HK1209741A1/xx unknown
- 2013-12-17 CA CA2895660A patent/CA2895660A1/en not_active Abandoned
- 2013-12-17 KR KR1020157019061A patent/KR20150097660A/ko not_active Withdrawn
- 2013-12-17 PE PE2015001056A patent/PE20151055A1/es not_active Application Discontinuation
- 2013-12-17 CN CN201380073218.3A patent/CN105143230B/zh not_active Expired - Fee Related
- 2013-12-17 WO PCT/IB2013/061043 patent/WO2014097148A1/en not_active Ceased
- 2013-12-17 SG SG11201504594QA patent/SG11201504594QA/en unknown
- 2013-12-17 JP JP2015548837A patent/JP6284546B2/ja not_active Expired - Fee Related
- 2013-12-17 AU AU2013365739A patent/AU2013365739A1/en not_active Abandoned
- 2013-12-17 AP AP2015008539A patent/AP2015008539A0/xx unknown
- 2013-12-17 EP EP13826625.9A patent/EP2935278B1/en active Active
- 2013-12-17 US US14/109,922 patent/US20140171417A1/en not_active Abandoned
- 2013-12-17 BR BR112015014292A patent/BR112015014292A2/pt not_active IP Right Cessation
- 2013-12-17 MX MX2015007939A patent/MX2015007939A/es unknown
- 2013-12-17 US US14/653,084 patent/US9359381B2/en active Active
- 2013-12-17 ES ES13826625.9T patent/ES2628369T3/es active Active
- 2013-12-18 TW TW102147023A patent/TW201429974A/zh unknown
- 2013-12-19 UY UY0001035211A patent/UY35211A/es not_active Application Discontinuation
- 2013-12-19 AR ARP130104861A patent/AR094122A1/es unknown
-
2015
- 2015-06-11 IL IL239389A patent/IL239389A0/en unknown
- 2015-06-16 TN TNP2015000279A patent/TN2015000279A1/fr unknown
- 2015-06-17 PH PH12015501386A patent/PH12015501386A1/en unknown
- 2015-06-18 CL CL2015001730A patent/CL2015001730A1/es unknown
- 2015-06-19 CU CUP2015000066A patent/CU20150066A7/es unknown
- 2015-06-19 CR CR20150325A patent/CR20150325A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CR20150325A (es) | 2015-08-10 |
| JP2016509579A (ja) | 2016-03-31 |
| WO2014097148A9 (en) | 2015-02-19 |
| CN105143230B (zh) | 2017-06-09 |
| MX2015007939A (es) | 2016-03-11 |
| CU20150066A7 (es) | 2015-11-27 |
| EA201591177A1 (ru) | 2015-11-30 |
| CN105143230A (zh) | 2015-12-09 |
| JP6284546B2 (ja) | 2018-02-28 |
| HK1209741A1 (en) | 2016-04-08 |
| US20150336986A1 (en) | 2015-11-26 |
| AU2013365739A1 (en) | 2015-07-09 |
| AP2015008539A0 (en) | 2015-06-30 |
| PE20151055A1 (es) | 2015-08-05 |
| TN2015000279A1 (en) | 2016-10-03 |
| EP2935278B1 (en) | 2017-03-15 |
| BR112015014292A2 (pt) | 2017-07-11 |
| PH12015501386A1 (en) | 2015-09-02 |
| US9359381B2 (en) | 2016-06-07 |
| SG11201504594QA (en) | 2015-07-30 |
| CL2015001730A1 (es) | 2015-08-28 |
| US20140171417A1 (en) | 2014-06-19 |
| WO2014097148A1 (en) | 2014-06-26 |
| UY35211A (es) | 2014-07-31 |
| KR20150097660A (ko) | 2015-08-26 |
| AR094122A1 (es) | 2015-07-08 |
| CA2895660A1 (en) | 2014-06-26 |
| ES2628369T3 (es) | 2017-08-02 |
| EP2935278A1 (en) | 2015-10-28 |
| IL239389A0 (en) | 2015-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW201429974A (zh) | 三環化合物 | |
| TWI736517B (zh) | 作為抗癌劑之新穎三環化合物 | |
| CN105209467B (zh) | 咪唑并吡咯烷酮衍生物及其在治疗疾病中的用途 | |
| EP2935277B1 (en) | Tricyclic compounds as cftr inhibitors | |
| TW201444831A (zh) | 作爲突變ｉｄｈ抑制劑之３－嘧啶－４－基－□唑啶－２－酮 | |
| CN110088096A (zh) | 作为泛素特异性蛋白酶7的抑制剂的哌啶衍生物 | |
| CN114728975A (zh) | 唑稠合的哒嗪-3(2h)-酮衍生物 | |
| TW201533044A (zh) | 經取代之黃嘌呤及其使用方法 | |
| TW202100524A (zh) | 用於治療hbv感染或hbv誘發疾病之稠合環嘧啶酮衍生物 | |
| TW201609698A (zh) | 三環磺醯胺衍生物 | |
| TW202334140A (zh) | 作為骨髓細胞上表現之觸發受體２促效劑之雜環化合物及其使用方法 | |
| TW202016116A (zh) | 作為a2a受體拮抗劑的吡唑並三唑並嘧啶衍生物 | |
| CN114478537A (zh) | 环酰胺并环化合物及其医药用途 | |
| HK40097443A (zh) | 作为ent抑制剂用於治疗癌症的大环二胺衍生物以及其与腺苷受体拮抗剂的组合 | |
| HK40089371A (zh) | 作为ent抑制剂用於治疗癌症的大环二胺衍生物以及其与腺苷受体拮抗剂的组合 | |
| HK40110644A (zh) | 具有ent1抑制活性的大环化合物 | |
| TW201524980A (zh) | 吡唑并吡咯啶衍生物及其治療疾病之用途 | |
| CN103492390A (zh) | 氟苯基双环杂芳基化合物 |